Predicting alcohol dependence from multi-site brain structural measures.


Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
01 2022
Historique:
revised: 21 09 2020
received: 12 06 2020
accepted: 06 10 2020
pubmed: 17 10 2020
medline: 29 3 2022
entrez: 16 10 2020
Statut: ppublish

Résumé

To identify neuroimaging biomarkers of alcohol dependence (AD) from structural magnetic resonance imaging, it may be useful to develop classification models that are explicitly generalizable to unseen sites and populations. This problem was explored in a mega-analysis of previously published datasets from 2,034 AD and comparison participants spanning 27 sites curated by the ENIGMA Addiction Working Group. Data were grouped into a training set used for internal validation including 1,652 participants (692 AD, 24 sites), and a test set used for external validation with 382 participants (146 AD, 3 sites). An exploratory data analysis was first conducted, followed by an evolutionary search based feature selection to site generalizable and high performing subsets of brain measurements. Exploratory data analysis revealed that inclusion of case- and control-only sites led to the inadvertent learning of site-effects. Cross validation methods that do not properly account for site can drastically overestimate results. Evolutionary-based feature selection leveraging leave-one-site-out cross-validation, to combat unintentional learning, identified cortical thickness in the left superior frontal gyrus and right lateral orbitofrontal cortex, cortical surface area in the right transverse temporal gyrus, and left putamen volume as final features. Ridge regression restricted to these features yielded a test-set area under the receiver operating characteristic curve of 0.768. These findings evaluate strategies for handling multi-site data with varied underlying class distributions and identify potential biomarkers for individuals with current AD.

Identifiants

pubmed: 33064342
doi: 10.1002/hbm.25248
pmc: PMC8675424
doi:

Types de publication

Journal Article Meta-Analysis Multicenter Study Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

555-565

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA013892
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA014100
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA020726
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024925
Pays : United States
Organisme : NIDA NIH HHS
ID : R01-DA020726
Pays : United States
Organisme : NIH HHS
ID : UL1-RR24925-01
Pays : United States
Organisme : NIDA NIH HHS
ID : R01DA047119
Pays : United States
Organisme : NIDA NIH HHS
ID : PL1 DA024859
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA047119
Pays : United States
Organisme : NIAAA NIH HHS
ID : ZIA AA000125-04 DICB
Pays : United States
Organisme : NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01-AA013892
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AA000125
Pays : United States
Organisme : NIDA NIH HHS
ID : R01-DA014100
Pays : United States
Organisme : NIDA NIH HHS
ID : PL30-1DA024859-01
Pays : United States
Organisme : NIDA NIH HHS
ID : T32DA043593
Pays : United States
Organisme : NIH HHS
ID : R01 DA018307
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA043593
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA018307
Pays : United States

Informations de copyright

© 2020 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.

Références

Neuropsychol Rev. 2007 Sep;17(3):239-57
pubmed: 17874302
Hum Brain Mapp. 2022 Jan;43(1):555-565
pubmed: 33064342
Neuroimage. 2006 Apr 1;30(2):436-43
pubmed: 16300968
Neuroimage Clin. 2014 Jul 05;5:420-37
pubmed: 26958467
Hum Brain Mapp. 2017 Mar;38(3):1208-1223
pubmed: 27774713
Drug Alcohol Depend. 2007 Nov 2;91(1):85-90
pubmed: 17590536
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Acta Psychiatr Scand. 2018 Mar;137(3):252-262
pubmed: 29377059
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Jun;4(6):589-599
pubmed: 30982583
Neurosci Biobehav Rev. 2016 Jul;66:92-103
pubmed: 27108216
Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Aug;5(8):748-758
pubmed: 31932230
J Neurosci Methods. 2014 Jun 15;230:37-50
pubmed: 24785589
Alcohol Clin Exp Res. 2002 Apr;26(4):558-64
pubmed: 11981133
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Evol Comput. 2018 Summer;26(2):269-297
pubmed: 28489414
Neuropsychopharmacology. 2008 May;33(6):1391-401
pubmed: 17653109
Science. 2015 Jul 17;349(6245):255-60
pubmed: 26185243
Schizophr Bull. 2009 Jan;35(1):1-2
pubmed: 19023121
Am J Psychiatry. 2019 Feb 1;176(2):119-128
pubmed: 30336705
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132

Auteurs

Sage Hahn (S)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, Vermont, USA.

Scott Mackey (S)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, Vermont, USA.

Janna Cousijn (J)

Department of Psychology, University of Amsterdam, Amsterdam, the Netherlands.

John J Foxe (JJ)

Department of Neuroscience & The Ernest J. Del Monte Institute for Neuroscience, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.

Andreas Heinz (A)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Robert Hester (R)

Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Australia.

Kent Hutchinson (K)

Department of Psychology and Neuroscience, University of Colorado, Boulder, Colorado, USA.

Falk Kiefer (F)

Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany.

Ozlem Korucuoglu (O)

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.

Tristram Lett (T)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Chiang-Shan R Li (CR)

Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

Edythe London (E)

David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.

Valentina Lorenzetti (V)

Monash Institute of Cognitive and Clinical Neurosciences & School of Psychological Sciences, Monash University, Melbourne, Australia.
School of Psychology, Faculty of Health Sciences, Australian Catholic University, Melbourne, Australia.
Department of Psychological Sciences, the University of Liverpool, Liverpool, UK.

Luijten Maartje (L)

Behavioural Science Institute, Radboud University, Nijmegen, the Netherlands.

Reza Momenan (R)

Clinical NeuroImaging Research Core, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.

Catherine Orr (C)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, Vermont, USA.

Martin Paulus (M)

VA San Diego Healthcare System and Department of Psychiatry, University of California San Diego, La Jolla, California, USA.
Laureate Institute for Brain Research, Tulsa, Oklahoma, USA.

Lianne Schmaal (L)

Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.

Rajita Sinha (R)

Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

Zsuzsika Sjoerds (Z)

Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Institute of Psychology, Cognitive Psychology Unit & Leiden Institute for Brain and Cognition, Leiden University, Leiden, the Netherlands.

Dan J Stein (DJ)

SA MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry & Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

Elliot Stein (E)

Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA.

Ruth J van Holst (RJ)

Department of Psychiatry, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, the Netherlands.

Dick Veltman (D)

Department of Psychiatry, VU University Medical Center, Amsterdam, the Netherlands.

Henrik Walter (H)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Reinout W Wiers (RW)

Department of Psychology, University of Amsterdam, Amsterdam, the Netherlands.

Murat Yucel (M)

David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Melbourne, Australia.

Paul M Thompson (PM)

Imaging Genetics Center, Stevens Institute for Neuroimaging & Informatics, Keck School of Medicine, University of Southern California, California, USA.

Patricia Conrod (P)

Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montreal, Quebec, Canada.

Nicholas Allgaier (N)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, Vermont, USA.

Hugh Garavan (H)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, Vermont, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH